bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. Our objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely bluebird bio is implementing good security practices.
Read more about the latest issues in cybersecurity
A data breach is a security incident where sensitive, protected confidential information is copied, ...
Cybersecurity is important because cybersecurity risk is increasing. Driven by global connectivity ...
Compare bluebird bio's security performance with other companies